Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer (Q39259483)

10 September 2017

title

Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer (English)

1 reference

10 September 2017

author

Manuela Martins-Green

4

object named as

Manuela Martins-Green

0 references

author name string

Ana Rocha

1

1 reference

10 September 2017

Lei Wang

2

1 reference

10 September 2017

Manuel Penichet

3

1 reference

10 September 2017

Manuela Martins-Green

4

1 reference

10 September 2017

language of work or name

English

0 references

publication date

12 October 2012

1 reference

Breast Cancer Research and Treatment

10 September 2017

published in

1 reference

10 September 2017

volume

136

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

647-658

1 reference

10 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Breast cancer chemoprevention: old and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

The pomegranate: nature's power fruit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

The antioxidant potency of Punica granatum L. Fruit peel reduces cell proliferation and induces apoptosis on breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Pomegranate (Punica granatum) juices: chemical composition, micronutrient cations, and antioxidant capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

The MARCKS brothers: a family of protein kinase C substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Cross-talk unfolded: MARCKS proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Regulated degradation of spindle assembly factors by the anaphase-promoting complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Nexilin: a novel actin filament-binding protein localized at cell-matrix adherens junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Chimaerins: GAPs that bridge diacylglycerol signalling and the small G-protein Rac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Protein kinase C epsilon: an oncogene and emerging tumor biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Epithelial-mesenchymal transitions: twist in development and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Mechanisms of motility in metastasizing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Strategies for the discovery and development of therapies for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Cytokines in cancer pathogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Interleukin-8 and human cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

The inflammatory chemokines CCL2 and CCL5 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

The PDGF family: four gene products form five dimeric isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

Chemokines and Cancer: A Fatal Attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2264-5

10.1007/S10549-012-2264-5

21 January 2018

Identifiers

DOI

1 reference

release_y4fqntd5hrhehhlguyxi7ytpfa

10 September 2017

Fatcat ID

0 references

1 reference